Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NOVEMBER (Novem- (9), BrEast Radiation), A Phase II Trial of a 9 Day Course of Whole Breast Radiotherapy for Early Stage Breast Cancer

NCT03345420 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT03345420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03345420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NOVEMBER (Novem- (9), BrEast Radiation), A Phase II Trial of a 9 Day Course of Whole Breast Radiotherapy for Early Stage Breast Cancer
Lead sponsor
University of Utah
Phase
Phase 2
Overall status
Completed
Start date
December 12, 2017
Completion date
June 26, 2025
Enrollment
102 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ductal breast carcinoma in situ, invasive breast carcinoma, stage 0 breast cancer, stage i breast cancer, stage ia breast cancer, stage ib breast cancer, stage ii breast cancer, stage iia breast cancer, stage iib breast cancer